Full-Time
Synapticure
51-200 employees
Telehealth services for neurodegenerative diseases
No salary listed
Mid
Chicago, IL, USA
Get referrals →
You have ways to get a Synapticure referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 3 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Active Medical Assistant Certification
- 2+ years experience as a Medical Assistant
- Adhering to HIPAA guidelines and standards, provides advocacy support on behalf of patients and families with clinical providers, billing and insurance companies, and other partners in the care team as needed.
- Maintains accountability to ensure high quality standards in client and partner interactions ensuring the highest levels of privacy and confidentiality.
- Follows standardized processes including operating procedures, quality assurance and documentation, in order to create high levels of efficiencies and effectiveness.
- Maintains positive and effective relationships within the multidisciplinary Care Coordination and broader Synapticure team to ensure a streamlined and supportive experience for patients.
- Collaborates with internal teams to ensure appropriate representation of Synapticure to external audiences.
- Nurtures and maintains positive and effective relationships with medical and community partners.
- Speaks expertly internally and externally about the program and company.
- Experience handling and reviewing medical records.
- Experience in a startup or organization that has experienced rapid growth and change.
- Experience in coordinating and managing referrals.
- Exceptional communication skills.
- Bilingual English/Spanish
Synapticure offers virtual healthcare for individuals and caregivers dealing with neurodegenerative diseases like ALS, Alzheimer’s, Huntington's, and Parkinson’s. Patients can access neurologists and behavioral health providers through telehealth, allowing them to receive care from home, which is especially beneficial for those with mobility issues. The company also provides integrated behavioral health services to address the emotional challenges of these conditions. Co-founders Brian Wallach and Sandra Abrevaya, who have personal experience with ALS, ensure that the services are empathetic and informed by the latest science.
Company Size
51-200
Company Stage
Series A
Total Funding
$31M
Headquarters
Chicago, Illinois
Founded
2019
Simplify's Take
What believers are saying
- Synapticure raised $25M in Series A funding to expand its virtual care services.
- Partnership with The Michael J. Fox Foundation enhances patient engagement and access to care.
- Telehealth reimbursement policies expansion makes virtual care more accessible and financially viable.
What critics are saying
- Increased competition from well-funded startups like Cortica could impact market share.
- Rapid expansion into additional conditions may strain resources and affect service quality.
- Reliance on partnerships for expansion could pose risks if they don't materialize.
What makes Synapticure unique
- Synapticure offers 24/7 access to neurologists and behavioral health providers via telehealth.
- The company integrates behavioral health services for neurodegenerative disease patients and caregivers.
- Co-founders' personal experience with ALS adds empathy and understanding to their services.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Unlimited Paid Time Off
Remote Work Options
Home Office Stipend
Professional Development Budget
Growth & Insights and Company News
6 month growth
↑ 1%1 year growth
↓ -4%2 year growth
↓ -1%In April 2023, Cortica received $75 million in a Series D funding round led by Optum Ventures.
Synapticure, a Chicago, IL-based virtual care company dedicated to improving access and outcomes for patients and caregivers living with Alzheimer's and related dementias, Parkinson's, and other neurodegenerative diseases, raised $25M in Series A funding
SynaptiCure has raised $25 million for its virtual approach to neurodegenerative disease care.
SALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN), through its wholly owned subsidiary Clene Nanomedicine Inc. in collaboration with Columbia University and Synapticure, has been awarded a four-year grant totaling $45.1 million from the National Institute of Neurological Disorders and Stroke (NINDS), a division of the National Institutes of Health (NIH), to support an Expanded Access Protocol (EAP) for the Company’s investigational drug, CNM-Au8®, in amyotrophic lateral sclerosis (ALS). An EAP is also referred to as Compassionate Use and is an FDA-regulated pathway that allows people with a serious and life-threatening disease to access an investigational drug that is not yet approved by the U.S. Food and Drug Administration (FDA)
As the first nationwide virtual clinic specializing in neurodegenerative disease, Synapticure scales leadership team to meet the rapidly growing needs of patients, payers and providersCHICAGO, Sept. 6, 2023 /PRNewswire/ -- Synapticure , a virtual clinic transforming treatment and outcomes for individuals and their caregivers living with neurodegenerative diseases, announced Joe Leinbach has joined as the company's first Chief Operating Officer. Leinbach joins at a critical time for the company's expansion into additional neurodegenerative conditions including Alzheimer's and related Dementias, while creating new ways to expand patient access through innovative partnerships with health systems and health plans.A veteran of early stage value-based care innovators, Leinbach has driven growth and operational success in leadership roles at Cityblock Health and Evolent Health. His background includes scaling operations to serve individuals with complex physical and behavioral health needs, and structuring partnerships with payers and providers to improve patient costs and outcomes. Joe will lead the company's next phase of growth and efforts to implement innovative models that directly benefit patients and partners.Founded in 2021 by Brian Wallach and Sandra Abrevaya, the co-founders of I AM ALS , Synapticure's care teams now provide services to all 50 states + DC, providing specialized neurology care, integrated behavioral health, and care coordination to help patients and their caregivers navigate the complexities of neurodegenerative diseases. Through proactive, patient-centered support, Synapticure's patients have enrolled in clinical trials they otherwise wouldn't have accessed, were prescribed new medications and supplements changing their quality of life, avoided costly hospitalizations and ER visits, and received support for issues with medical equipment, insurance benefits and other care needs.Story continues"We've proven that patients and caregivers love working with Synapticure's specialized neurologists, as shown by our incredible NPS (Net Promoter Score) of 95